» Articles » PMID: 32781922

Efficacy and Safety of Greater Occipital Nerve Block for the Treatment of Cluster Headache: a Systematic Review and Meta-analysis

Overview
Specialties Neurology
Pharmacology
Date 2020 Aug 13
PMID 32781922
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The treatment of cluster headache (CH) is challenging in view of the few evidence-based treatments. The authors aim to summarize the evidence of efficacy and safety of greater occipital nerve blocks (GONBs) in CH.

Areas Covered: The authors included papers indexed in PubMed and Web of Science from the beginning of indexing to 5 May 2020. They included both observational and randomized studies referring to patients with episodic and/or chronic CH. The authors identified 12 studies on 365 patients. Five studies (two randomized controlled trials) could be included in the meta-analyses. The pooled proportion of pain-free subjects at 1 month was 50% (95% CI 24-76%) with considerable heterogeneity (I = 88%; P < 0.01). The pooled relative risk ratio of pain freedom at 1 month in active versus control groups in the two included randomized controlled trials was 4.86 (95% CI, 1.35-17.55) without statistical heterogeneity (I = 0%; P = 0.39). Three studies showed decreased attack intensity, frequency, and duration after GONBs. The studies reported mild and transient adverse events.

Expert Opinion: Despite several limitations and considerable heterogeneity, the available data support the efficacy and safety of GONBs for the treatment of CH. Further large randomized trials are needed to confirm efficacy and establish optimal treatment protocols.

Citing Articles

Ketamine as Treatment for Cluster Headache: A Systematic Review of Literature and a Case Series.

Neumann J, Bornemann-Cimenti H, Rumpold-Seitlinger G, Lang-Illievich K, Klivinyi C Pain Ther. 2024; 13(3):651-662.

PMID: 38722484 PMC: 11111424. DOI: 10.1007/s40122-024-00606-5.


A prospective open label 2-8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headache.

Brandt R, Wilbrink L, de Coo I, Haan J, Mulleners W, Huygen F EBioMedicine. 2023; 98:104895.

PMID: 38007947 PMC: 10755111. DOI: 10.1016/j.ebiom.2023.104895.


Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol.

Davide M, Giacomo U, Maria A, Eleonora M, Valentina F, Giulia P Neurol Sci. 2022; 43(9):5777-5778.

PMID: 35750950 DOI: 10.1007/s10072-022-06198-2.


Algometer Assessment of Pressure Pain Threshold After Onabotulinumtoxin-A and Physical Therapy Treatments in Patients With Chronic Migraine: An Observational Study.

Deodato M, Granato A, Ceschin M, Galmonte A, Manganotti P Front Pain Res (Lausanne). 2022; 3:770397.

PMID: 35295800 PMC: 8915742. DOI: 10.3389/fpain.2022.770397.


Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study.

Merli E, Asioli G, Favoni V, Zenesini C, Mascarella D, Sartori A J Neurol. 2021; 269(4):2193-2199.

PMID: 34820736 PMC: 8940833. DOI: 10.1007/s00415-021-10884-0.